Mesoblast Shares Climb as Celgene Invests $45 Million

Mesoblast traded as much as 27 percent higher at A$4.07, its biggest intraday gain since December 2010. The stock was trading at A$3.94 as of 12:19 p.m. local time.

http://washpost.bloomberg.com/Story?docId=1376-NMPZ4J6JIJUO01-07CSD7M8E6FT9PEJQU47BQCUNN